Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : BIOP <--------------- MEDICAL SCAM or CURE ?? -- Ignore unavailable to you. Want to Upgrade?

To: Judgement Proof.com who wrote (51)	3/1/2001 1:19:28 AM
From: bwdik	Read Replies (1) \| Respond to of 66

BIOP WELL DONE ALL

To: Judgement Proof.com who wrote (51)	3/9/2001 5:39:59 PM
From: Judgement Proof.com	Read Replies (1) \| Respond to of 66

BioPulse Says It's Dumping Liviakis Friday March 9, 5:00 am Eastern Time Press Release SOURCE: BioPulse International, Inc. BioPulse Addresses Letter to Shareholders SAN DIEGO, March 9 /PRNewswire/ -- BioPulse International, Inc., (OTC Bulletin Board: BIOP.OT; Frankfurt: BPZ) today posted a letter to its shareholders on its website, www.biopulse.com. To BioPulse Shareholders, In response to many inquiries, we make known the fact that we have severed our relationship with the investor relations firm which had been representing the company. We are currently in discussions with several investor and public relations firms and will handle these matters ourselves directly until a new firm is retained. As we announced previously, Reid Jilek, Ph.D., has accepted the position of Chairman and CEO of BioPulse International, Inc. Dr. Jilek is experienced in the biotech field and has been conducting a thorough review of the company's business plans and objectives. Jonathan Neville remains on the Board of Directors and will continue to serve the company. The clinic in Mexico continues to operate as it has for the last year. Once the Mexican doctors learned that a special permit was required for certain treatments, they initiated the application process in cooperation with the health department. The plan we previously announced to sell certain assets, mostly equipment, to the group of doctors continues to be negotiated together with a technology license. Our company's plan has been and remains to collaborate with established clinics and not to own them. We hope to be able to expand the number of clinics with which we have relationships as we believe we can, in this way, both assist more patients and expand our company's operations. Sincerely, The Board of Directors Various statements made within this letter may constitute ``forward-looking statements'' for purposes of the Securities and Exchange Commission's ``safe harbor'' provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company's expectations. Except as required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. CONTACT: Jan Morse of BioPulse International, Inc., 801-523-0101. SOURCE: BioPulse International, Inc.